Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo E Perez

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Cancer Biology & Therapy|October 6, 2018
Alpha ketoglutarate levels, regulated by p53 and OGDH, determine autophagy and cell fate/apoptosis in response to Nutlin-3aLei Duan, Ricardo E Perez, Carl G Maki
Cancers|May 25, 2024
Schlafens: Emerging Therapeutic TargetsRicardo E Perez, Frank Eckerdt, Leonidas C Platanias
Scientific Reports|January 21, 2022
RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLCLei Duan, Ricardo E Perez, Sarah Calhoun, et al.
Cancer Biology & Therapy|January 31, 2022
Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15Lei Duan, Ricardo E Perez, Sarah Calhoun, et al.
Cancer Biology & Therapy|February 3, 2018
DZNep represses Bcl-2 expression and modulates apoptosis sensitivity in response to Nutlin-3aYalu Zhou, Ricardo E Perez, Lei Duan, et al.
Plos One|April 6, 2013
Two 4N cell-cycle arrests contribute to cisplatin-resistanceHong Shen, Ricardo E Perez, Batzaya Davaadelger, et al.
Frontiers in Immunology|December 17, 2020
Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling PathwaysCandice Mazewski, Ricardo E Perez, Eleanor N Fish, et al.
Oncotarget|April 7, 2016
Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitorBatzaya Davaadelger, Lei Duan, Ricardo E Perez, et al.
Cancer Biology & Therapy|December 9, 2014
Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1Lei Duan, Ricardo E Perez, Michael Hansen, et al.
The Journal of Biological Chemistry|May 1, 2019
The histone demethylase JMJD2B is critical for p53-mediated autophagy and survival in Nutlin-treated cancer cellsLei Duan, Ricardo E Perez, Xin Lai, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Cancer Biology & Therapy|October 6, 2018
Alpha ketoglutarate levels, regulated by p53 and OGDH, determine autophagy and cell fate/apoptosis in response to Nutlin-3aLei Duan, Ricardo E Perez, Carl G Maki
Cancers|May 25, 2024
Schlafens: Emerging Therapeutic TargetsRicardo E Perez, Frank Eckerdt, Leonidas C Platanias
Scientific Reports|January 21, 2022
RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLCLei Duan, Ricardo E Perez, Sarah Calhoun, et al.
Cancer Biology & Therapy|January 31, 2022
Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15Lei Duan, Ricardo E Perez, Sarah Calhoun, et al.
Cancer Biology & Therapy|February 3, 2018
DZNep represses Bcl-2 expression and modulates apoptosis sensitivity in response to Nutlin-3aYalu Zhou, Ricardo E Perez, Lei Duan, et al.
Plos One|April 6, 2013
Two 4N cell-cycle arrests contribute to cisplatin-resistanceHong Shen, Ricardo E Perez, Batzaya Davaadelger, et al.
Frontiers in Immunology|December 17, 2020
Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling PathwaysCandice Mazewski, Ricardo E Perez, Eleanor N Fish, et al.
Oncotarget|April 7, 2016
Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitorBatzaya Davaadelger, Lei Duan, Ricardo E Perez, et al.
Cancer Biology & Therapy|December 9, 2014
Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1Lei Duan, Ricardo E Perez, Michael Hansen, et al.
The Journal of Biological Chemistry|May 1, 2019
The histone demethylase JMJD2B is critical for p53-mediated autophagy and survival in Nutlin-treated cancer cellsLei Duan, Ricardo E Perez, Xin Lai, et al.
Pageof 4